Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.05 AUD | +31.25% |
|
+169.23% | +16.67% |
Business Summary
Sales per Business
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Cannabinoid-based Medicines
100.0
%
| 2 | 100.0 % | 0 | 100.0 % | -80.45% |
Sales per region
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
70.9
%
| 1 | 95.7 % | 0 | 70.9 % | -85.51% |
Australia
29.1
%
| 0 | 4.3 % | 0 | 29.1 % | +31.03% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Oludare Odumosu
CEO | Chief Executive Officer | - | 19-11-27 |
Rahul Ganesan
DFI | Director of Finance/CFO | - | - |
Greg Blake
BRD | Director/Board Member | - | 19-12-31 |
Timothy Slate
BRD | Director/Board Member | - | 16-10-19 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Osagie Imasogie
CHM | Chairman | 62 | 19-11-27 |
Timothy Slate
BRD | Director/Board Member | - | 16-10-19 |
Oludare Odumosu
CEO | Chief Executive Officer | - | 19-11-27 |
Greg Blake
BRD | Director/Board Member | - | 19-12-31 |
Donna O’Donnell
BRD | Director/Board Member | - | 23-05-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 11,347,155 | 5,820,324 ( 51.29 %) | 0 | 51.29 % |
Company contact information
Zelira Therapeutics Ltd.
101 St George’s Terrace Level 3
6000, Perth
+61 8 6558 0886
http://zeliratx.com![address Zelira Therapeutics Limited(ZLD)](https://cdn.zonebourse.com/static/address/31637152.png)
Sector
Sales per region
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+16.67% | 6.15M | |
+20.63% | 127B | |
+25.04% | 27.67B | |
-20.17% | 20.33B | |
-17.12% | 16.79B | |
-18.07% | 15.63B | |
-47.70% | 14.65B | |
+11.92% | 14.84B | |
+58.32% | 14.43B | |
+149.98% | 12.49B |
- Stock Market
- Equities
- ZLD Stock
- Company Zelira Therapeutics Limited